Approach to the critically ill patient with advanced HIV in low resource settings. Sebastian Albus, MD MSF, Operational Center Bruxelles

Similar documents
Advanced HIV and seriously ill: challenges in low resource settings Rosie Burton, Southern African Medical Unit, MSF

TB and HIV co-infection including IRIS

Cryptococcal Meningitis

Challenge - Advanced HIV in Antiretroviral- Experienced Patients. Esther C. Casas South African Medical Unit Medecins Sans Frontieres

TB & HIV CO-INFECTION IN CHILDREN. Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012

The clinical utility of the urine based lateral flow lipoarabinomannan (LF-LAM) assay in HIV infected adults in Myanmar.

EPG Clinical Guidelines

Urinary TB diagnostics in HIV

MSF HIV/TB. clinical guide REFERRAL LEVEL. July 2017

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

MSF HIV/TB Guide HOSPITAL LEVEL. February 2018

Aetiology of meningitis at the Moi Teaching and Referral Hospital, Eldoret, Kenya. D. K. Lagat, MBChB, Mmed(Moi)

CNS Infections. Philip Gothard Consultant in Infectious Diseases Hospital for Tropical Diseases, London. Hammersmith Acute Medicine 2011

High-dose rifampicin for the Treatment of TB Meningitis: a dose-finding study

MANAGEMENT OF SUSPECTED VIRAL ENCEPHALITIS IN CHILDREN

Modeling the diagnosis of HIVassociated

7/17/2013. Evaluation of Diagnostic Tests July 22, 2013 Introduction to Clinical Research: A Two week Intensive Course

Immune Reconstitution Inflammatory Syndrome. Dr. Lesego Mawela

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

SA TB Guidelines The interface with Advanced Clinical Care

Opportunistic infections in the era of cart, still a problem in resource-limited settings

Advanced HIV Disease / AIDS

Rapid PCR TB Testing Results in 68.5% Reduction in Unnecessary Isolation Days in Smear Positive Patients.

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

Evidence- Based Medicine Fluid Therapy

UPDATE IN HOSPITAL MEDICINE

OPPORTUNISTIC INFECTIONS. Institute of Infectious Diseases, Pune India

medical monitoring: clinical monitoring and laboratory tests

Dilemmas in the Management of Meningitis & Encephalitis HEADACHE AND FEVER. What is the best initial approach for fever, headache, meningisums?

CNS Infections in the Pediatric Age Group

Case 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1

Diagnosis of tuberculosis in children

Challenges in Management of Cryptococcal Meningitis. Yunus Moosa Department of ID NRMSM Durban

TB: A Supplement to GP CLINICS

Developing strategies for TB screening among HIV-infected and HIV-uninfected pregnant and postpartum women in Swaziland

Example Clinician Educational Material for Providers of Immune Effector Cellular Therapy

Supplementary Appendix

Dr Francis Ogaro MTRH ELDORET

TB and Comorbidities Adriana Vasquez, MD April 12, 2018

Exam 1 Review. Cardiopulmonary Symptoms Physical Examination Clinical Laboratory Studies

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012

11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad.

Outline. Cryptococcosis Pneumocystosis Diarrhea. Case Histories: HIV Related- Opportunistic Infections in 2015

Management of Immune Reconstitution Inflammatory Syndrome (IRIS)

Gary Reubenson 16 October 2012 PAEDIATRIC TUBERCULOSIS: AN OVERVIEW IN 40 MINUTES!!

Variable Name Variable Label Answer Label Answer Code

Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm

Tuberculosis Intensive

Case presentation. Dr REESAUL R

TUBERCULOUS MENINGITIS IN CHILDREN-CLINICAL PROFILE, MORTALITY AND MORBIDITY OF BACTERIOLOGICALLY CONFIRMED CASES

Comparative evaluation of diagnostic performance of Xpert between paired IS and GW in children <3.5 years in Cape Town, SA

The Lancet Infectious Diseases

HIV/TB Co infection TB Clinical Intensive October 11, 2018

Acute changes in condition: Caring for a child with myocarditis. Looking at the first 48 hours of admission

CD4 WORKSHOP REPORT JULY 22, 2017

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

Management of Cryptococcal Meningitis in HIV-infected children in National Pediatric Hospital

Opportunistic Infections BHIVA Guidelines

Cryptococcosis of the Central Nervous System: Classical and Immune-Reconstitution Disease

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf

Extra pulmonary Tuberculosis

Using Big Data to Prevent Infections

Natural History of Untreated HIV-1 Infection

Diagnosis and Treatment of Tuberculosis, 2011

Fever in children aged less than 5 years

LEFT BEHIND BY THE HIV RESPONSE

3.1. Uniform research case definition criteria differentiate tuberculous and bacterial meningitis in children. R.S. Solomons M. Wessels D.H.

SURVEY FINDINGS April 28, 2017

CLAIRE NOWLAN & SAM SEARLE. Pneumonia in the nursing home

Clinical syndromes: experience from the bedside. Professor Rob Miller University College Hospital, London

Case Management of the TB/HIV Infected Patient

Chapter 22. Pulmonary Infections

Meningi&s in HIV NORTHWEST AIDS EDUCATION AND TRAINING CENTER

Pneumonia in the Hospitalized

A RARE NEUROLOGICAL PRESENTATION OF SLE. Dr Yoganand M N Dr Prithvi P Nayak

TB in the Patient with HIV

Case Report Diagnosis of Cryptococcosis and Prevention of Cryptococcal Meningitis Using a Novel Point-of-Care Lateral Flow Assay

High Impact Rheumatology

Acute Encephalitis in Children at Port Moresby General Hospital:

A Child with Cross Eye. Nia Kurniati

INTENSIFIED TB CASE FINDING

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

Invasive Pulmonary Aspergillosis in

ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS

Fungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern

AIDS at 25. Epidemiology and Clinical Management MID 37

Clinical presentation Opportunistic infections

Pneumonia Severity Scores:

INITIATING ART IN CHILDREN: Follow the six steps

KAP conference 19 th March 2008: Dr Mohamed Hussein Jin.

Diagnostic challenges of active childhood TB in Tanzania. Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre

Physiotherapy on the Intensive Care Unit. Information for patients, their family and carers

Update on TB-IRIS. Graeme Meintjes. University of Cape Town Imperial College London

Immune Reconstitution Inflammatory Syndrome - IRIS

Managing meningitis not just antibiotics. Helena White December 2013

CHART ELEVEN (11) KENYAN FIGURES (KENYA DEMOGRAPHIC HEALTH SURVEY REVISED 2004)

Community Acquired Pneumonia

Cost-effectiveness of ART and the Three I s for HIV/TB to prevent tuberculosis

Transcription:

Approach to the critically ill patient with advanced HIV in low resource settings Sebastian Albus, MD MSF, Operational Center Bruxelles

why You should be this guy.

instead of that guy

ME USFR, Guinea-Conakry 1 childhood safari to Kenya Read Heart of Darkness 2 years experience in Infectious diseases department in Germany just built 30 beds, 4 (level 2) ICU beds 10 nurses, 4 national doctors, 1 nurse supervisor Mission: treat advanced HIV cases What could go wrong??

Mortality USFR during first two months of activity Improved 50% DCD 50% n=50

Deceased patients by length of stay 11/16-12/16 >48 hrs 52% <48 hrs 48% n=25

Whats going on

A readymade Definition A critically ill patient with advanced HIV is a patient with (advanced immunosupression) and one or more life-threatening (opportunistic) infections

Three boxes for three problems Acute Problem TB Problem HIV Problem

Danger signs? Coma Heart rate>120/min Resp. rate >30/min Unable to walk unaided Malnutrition Any neuro signs???? Clinical Presenting complaint(s) For how long? Where(CNS,chest,abdo)? How many levels? Establish and maintain diagnostic algorythms RDTs (Malaria, LAM,CRAG, Xpert, Glucose) bloods CXR Ultrasound Lumbar puncture Organisation Establish and maintain treatment algorythms Shock CPR Seizures Hypoglycaemia Transfusion

History Could this be TB? Actively look for TB in ALL NEW patients XRAY Ultrasound LP Examination LAM Xpert (Smear) culture Is this patient already on TB treatment? How was TB initially diagnosed For how long has the patient been treated Why is he not improving Recently started ARVs? adherence? Resistance? Alternative diagnosis?

3200 autopsies 43% (95% CI 38.0 48.3%) of facility based HIV related adult deaths Cause of death in >90% of cases 50% undiagnosed at death

How do we diagnose anything? WE ASK YES OR NO History QUESTIONS Examination Tests Bedside Laboratory Blood Sputum Urine Other fluids and tissues Radiology X-ray USS

Diagnostic accuracy studies Test +ve Test -ve Has disease True positive A False negative C Doesn t have disease False positive B True negative D Sensitivity A/(A+C) Specificity D/(B+D) PPV NPV Likelihood ratios

GeneXpert Detects MTB DNA PCR Amplification Detects Rif resistance Can stay + during treatment

Sensitivity 89% Specificity 99%

Pooled sensitivity was 56% (98%CI, 41-70%) pooled specificity was 90%

lets see a patient 26 year old woman Diagnosed with HIV this admission ART naïve, CD4 = 17 Presents with: Fevers, night sweats shortness of breath for 3 weeks Examination: RR 40 saturation 82% on room air Temp 37 7 No lymphadenopathy Chest clear on examination TB

negative

So can we rule out TB?????? All tests say no but can we trust this no???

Diagnostic tests Test +ve Test -ve Has TB True positive A False negative C Doesn t have TB False positive B True negative D Sensitivity = A/ (A+C) Negative predictive value = D/(C+D)

3200 autopsies 43% (95% CI 38.0 48.3%) of facility based HIV related adult deaths Cause of death in >90% of cases 50% undiagnosed at death

..it could always be TB Toxoplasmosis 3% Kidney failure 1% bacterial meningitis 1% bacterial Pneumonia 2% Diarreah 2% Cryptococal meningitis 3% KS 3% Hepatotoxicity 3% Others 12% TB IRIS 1% 67% PCP 3% USFR patients from 11/16-11/17 n= 547

TB cases USFR 11/17-11/18 (n=310) LAM-; Xpert- 28,7% (n=89)

..Ideally Ideally.

Organize standard algorythms Test agressive If necessary treat agressive+ empirical Become serious HIV Nerd+ make everybody else become one too DONT EVER EXCLUDE TB

Vielen Dank für die Aufmerksamkeit

Questions..??? or

Practice Session

Case study 26 year old man,hiv diagnosed this admission: Presents with: Seizures Danger Signs? Confusion Fever Examination Immediate measures? RespRate 36, saturation 87% RR 90/40, HR 110/min Bilateral crepitations Meningism CD4? Presenting Complaint/ levels? Time Course?

Additional tests? Xpert Lam scrag negative positive negative LP: WBC 120 (10% Neutrophiles), Pandy++, Glucose 10 mg/dl, CRAG-

Differential diagnosis Disseminated TB: pulmonary, TBM Pneumocystis pneumonia plus another infection cause of meningitis Bacterial pneumonia plus meningitis, bacterial or other cause

how will you treat this patient? Advanced disease, respiratory and neurological danger signs Empiric treatment: TB treat for TBM Pneumocystis pneumonia Crypto ruled out Antibiotics? Deok-Jong Yoo 2010

TB Meningitis Common cause of meningitis in countries with high HIV/TB prevalence CNS involvement is 5 x higher in HIV positive pts with TB Mortality 30-70%; neurological sequelae in 25%

TB meningitis: pathology

TB meningitis: pathology Dense gelatinous exudate - most florid around base of brain cranial nerve palsies from inflammation surrounding nerves Vasculitis hydrocephalus

Treatment: Some guidelines prolong the continuation phase: 2 months of RHEZ 7-10 months of RH (South Africa: 7 months) Optimal regimen/duration is active research area: Watch out for new evidence High dose rifampicin? Quinolones?

Corticosteroids for TB meningitis Improved survival for HIV negative patients with TBM Trend for improved survival in HIV positive pts Recommended for all patients irrespective of HIV status Studies used intravenous dexamethasone Most resource-poor, high prevalence countries use oral prednisone: 1.5mg/kg/day x 4 weeks then 0.75mg/kg/day x 2 weeks

Prognosis High mortality 20-50% with treatment Neurological impairment amongst survivors - 20-30%: cranial nerve palsies hemiparesis seizures blindness Prognosis worse: more severe disease at presentation: decreased consciousness, focal neurology